Shandong Focusfreda Biotech Co.Ltd always focus on the research and development and production of sodium hyaluronate and HA derivatives.Our company has advanced production equipment and technical team, and is committed to providing high-quality sodium hyaluronate series products to global customers. At the same time, we also offer customers with many solutions, such as OEM/ODM and product different raw materials upon their requests.We currently have two plants. The first factory was set up in 2012 and put into operation in the same year. In 2019, we built a much larger factory with an annual output of about 300 tons. Two factories have a total investment of 640 million yuan, covering an area of 150,000 square meters and an annual output of 420 tons. Our products have undergone strict quality control and testing, meet international quality standards, and have passed a number of certifications and inspections such as KOSHER, HALAL, EFfCI GMP, ISO22000, IS09001, ISO14001, ISO45001, ECOCERT, COSMOS , CEP and VEGAN, which prove that we attach great importance to quality and safety in the production process. Our headquarters Freda Group has a total of 276 authorized patents. Our team participates in major international raw material exhibitions every year, such as In Cosmetics Spain, Vitafoods Switzerland, Suppliers Day New York, CPHI Shanghai, In Cosmetics Korea, Fi South America, SSW, CPHI Barcelona and CPHI Korea, Asia.